Find Leuprolide Mesylate manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

KDMF

KDMF

0

VMF

NDC API

API REF. PRICE (USD/KG)

MARKET PLACE

0

API

0

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

PATENTS & EXCLUSIVITIES

0

Health Canada Patents

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Finished Drug Prices

NA

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: Leuprorelin mesilate, Leuprorelin mesylate, Camcevi, 8e3c3c493w, Pglu-his-trp-ser-tyr-d-leu-leu-arg-pro-nhc2h5 mesylate, Pglu-his-trp-ser-tyr-d-leu-leu-arg-pro-nhc2h5 methanesulfonate
Molecular Formula
C60H88N16O15S
Molecular Weight
1305.5  g/mol
InChI Key
MBIDSOMXPLCOHS-XNHQSDQCSA-N
FDA UNII
8E3C3C493W

Leuprolide Mesylate
1 2D Structure

Leuprolide Mesylate

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
(2S)-N-[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2R)-1-[[(2S)-1-[[(2S)-5-(diaminomethylideneamino)-1-[(2S)-2-(ethylcarbamoyl)pyrrolidin-1-yl]-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]-5-oxopyrrolidine-2-carboxamide;methanesulfonic acid
2.1.2 InChI
InChI=1S/C59H84N16O12.CH4O3S/c1-6-63-57(86)48-14-10-22-75(48)58(87)41(13-9-21-64-59(60)61)68-51(80)42(23-32(2)3)69-52(81)43(24-33(4)5)70-53(82)44(25-34-15-17-37(77)18-16-34)71-56(85)47(30-76)74-54(83)45(26-35-28-65-39-12-8-7-11-38(35)39)72-55(84)46(27-36-29-62-31-66-36)73-50(79)40-19-20-49(78)67-40;1-5(2,3)4/h7-8,11-12,15-18,28-29,31-33,40-48,65,76-77H,6,9-10,13-14,19-27,30H2,1-5H3,(H,62,66)(H,63,86)(H,67,78)(H,68,80)(H,69,81)(H,70,82)(H,71,85)(H,72,84)(H,73,79)(H,74,83)(H4,60,61,64);1H3,(H,2,3,4)/t40-,41-,42-,43+,44-,45-,46-,47-,48-;/m0./s1
2.1.3 InChI Key
MBIDSOMXPLCOHS-XNHQSDQCSA-N
2.1.4 Canonical SMILES
CCNC(=O)C1CCCN1C(=O)C(CCCN=C(N)N)NC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CO)NC(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)C(CC5=CN=CN5)NC(=O)C6CCC(=O)N6.CS(=O)(=O)O
2.1.5 Isomeric SMILES
CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CC2=CC=C(C=C2)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC3=CNC4=CC=CC=C43)NC(=O)[C@H](CC5=CN=CN5)NC(=O)[C@@H]6CCC(=O)N6.CS(=O)(=O)O
2.2 Other Identifiers
2.2.1 UNII
8E3C3C493W
2.3 Synonyms
2.3.1 Depositor-Supplied Synonyms

1. Leuprorelin Mesilate

2. Leuprorelin Mesylate

3. Camcevi

4. 8e3c3c493w

5. Pglu-his-trp-ser-tyr-d-leu-leu-arg-pro-nhc2h5 Mesylate

6. Pglu-his-trp-ser-tyr-d-leu-leu-arg-pro-nhc2h5 Methanesulfonate

7. 1-9-luteinizing Hormone-releasing Factor (swine), 6-d-leucine-9-(n-ethyl-l-prolinamide)-, Methanesulfonate (1:1)

8. 944347-41-5

9. Unii-8e3c3c493w

10. Schembl4075500

11. Chembl4802223

12. Leuprorelin Mesilate [who-dd]

13. Leuprolide Mesylate [orange Book]

14. Q27270242

2.4 Create Date
2014-05-03
3 Chemical and Physical Properties
Molecular Weight 1305.5 g/mol
Molecular Formula C60H88N16O15S
Hydrogen Bond Donor Count16
Hydrogen Bond Acceptor Count17
Rotatable Bond Count32
Exact Mass1304.63357734 g/mol
Monoisotopic Mass1304.63357734 g/mol
Topological Polar Surface Area494 Ų
Heavy Atom Count92
Formal Charge0
Complexity2480
Isotope Atom Count0
Defined Atom Stereocenter Count9
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count2
4 Drug and Medication Information
4.1 Drug Indication

Camcevi is indicated for the treatment of hormone dependent advanced prostate cancer and for the treatment of high-risk localised and locally advanced hormone dependent prostate cancer in combination with radiotherapy.


API Reference Price

read-more
read-more
[{"dataSource":"API Import","activeIngredients":"","year":"2021","qtr":"Q2","strtotime":1624386600,"product":"LEUPROLIDE MESYLATE","address":"2ND FLOOR, CHINUBHAI CENTRE,OFF. NEHRU BRIDGE, ASHRAM ROAD,","city":"AHMEDABAD, GUJARAT","supplier":"SCINOPHARM TAIWAN, LTD","supplierCountry":"TAIWAN","foreign_port":"TAIPEI","customer":"INTAS PHARMACEUTICALS","customerCountry":"INDIA","quantity":"0.20","actualQuantity":"0.2","unit":"KGS","unitRateFc":"500000","totalValueFC":"102886.1","currency":"USD","unitRateINR":"37834125","date":"23-Jun-2021","totalValueINR":"7566825","totalValueInUsd":"102886.1","indian_port":"BOMBAY AIR","hs_no":"29335990","bill_no":"4425212","productDescription":"API","marketType":"REGULATED MARKET","country":"TAIWAN","selfForZScoreResived":"Pharma Grade","supplierPort":"TAIPEI","supplierAddress":"","customerAddress":"2ND FLOOR, CHINUBHAI CENTRE,OFF. NEHRU BRIDGE, ASHRAM ROAD,"},{"dataSource":"API Import","activeIngredients":"","year":"2022","qtr":"Q2","strtotime":1648751400,"product":"CHEMICAL : LEUPROLIDE MESYLATE","address":"CORPORATE HOUSE, NR. SOLA BRIDGE,,","city":"AHMEDABAD,GUJARAT","supplier":"SCINOPHARM TAIWAN, LTD","supplierCountry":"TAIWAN","foreign_port":"TAIPEI","customer":"INTAS PHARMACEUTICALS","customerCountry":"INDIA","quantity":"1.00","actualQuantity":"1","unit":"KGS","unitRateFc":"290500","totalValueFC":"296087.1","currency":"USD","unitRateINR":"22339450","date":"01-Apr-2022","totalValueINR":"22339450","totalValueInUsd":"296087.1","indian_port":"Ahmedabad-ZIPL-SEZ","hs_no":"29335990","bill_no":"1001303","productDescription":"API","marketType":"REGULATED MARKET","country":"TAIWAN","selfForZScoreResived":"Pharma Grade","supplierPort":"TAIPEI","supplierAddress":"NO.1 NAN-KE 8TH ROAD SOUTHERN TAIWAN SCIENCE PARK SHAN-HUA,TAINAN 74144 TW","customerAddress":"CORPORATE HOUSE, NR. SOLA BRIDGE,,"}]
23-Jun-2021
01-Apr-2022
KGS
overview
Loading...

Average Price (USD/KGS)

Number of Transactions

Total Quantity (KGS)

Total Value (USD)

Quantity (KGS) & Unit rate (USD/KGS) over time

API Imports and Exports

Importing Country Total Quantity
(KGS)
Average Price
(USD/KGS)
Number of Transactions

Upgrade, download data, analyse, strategize, subscribe with us contact

Digital Content read-more

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

Patents & EXCLUSIVITIES

Check the patents & exclusivity for this product

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty